By Topic

Computing in drug discovery: the design phase

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)
Lunney, E.A. ; Pfizer Global Res. & Dev., San Diego, CA, USA

Drug discovery is an extended process that can take as many as 15 years from the first compound synthesis in the laboratory until the therapeutic agent, or drug, is brought to market. Reducing the research timeline in the discovery stage is a key priority for pharmaceutical companies worldwide, and through the application and collaboration of current, advanced technologies, the industry is poised to achieve that goal. This article highlights computational chemistry, a technology that can play an important role in expediting the drug design phase

Published in:

Computing in Science & Engineering  (Volume:3 ,  Issue: 5 )